August 12th, 2024 – INCATE, the INCubator for Antibacterial Therapies in Europe, is pleased to announce that Iringó Demeter has joined the Management Team.

Iringó Demeter is a versatile expert in the life science industry with almost 20-year experience in supporting ventures in navigating and accelerating their ideas and business through their life cycle. She brings a 360-degree mindset into the team with her extensive expertise in business development, valuation of life science projects, and strategic management of biotech companies. In addition, Iringó has supported numerous innovators in bridging the gap between an idea and having their own venture. Iringó holds a master degree in Microbiology-Genetics and a Master in Business Administration.

“I am excited to join INCATE and to contribute to its important mission of combating antimicrobial resistance, an underestimated leading cause of death worldwide,” said Iringó Demeter. “I am looking forward to leveraging my experience to support young ventures and build strategic alliances to grow and advance INCATE to the next stage together with a driven and experienced team.”

“We are thrilled to have Iringó on board,” said Christoph Dehio, Director of the Swiss National Centre of Competence in Research AntiResist. “Her deep understanding of the biotech landscape and her passion for innovation are in perfect alignment with INCATE’s goals.” Helmut Kessmann, on behalf of the INCATE Team, added “Iringó adds great strength to our ability to support groundbreaking projects addressing antimicrobial resistance and grow INCATE to the next level, for an even major impact in the fight against AMR.”

About INCATE 

INCATE is a not-for-profit partnership which brings together translational and basic research, industry, experienced entrepreneurs, investors and NGOs from across Europe and beyond. The German Center for Infection Research (DZIF), the Leibniz:HKI (member if the Leibniz Association) in Germany, the Swiss National Centre of Competence in Research AntiResist, and the University of Basel are the academic founding members of INCATE with the University of Basel acting as the host. Together with BIOASTER (Lyon, France) and the four industry partners Boehringer Ingelheim, Roche, Shionogi and MSD as well as other organizations, funders, and investors, INCATE wants to support the global community interested to combat AMR and to ensure that the pipeline of new antibiotics and technology platforms is filled and strengthened.